{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T19:04:08Z","timestamp":1784574248715,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Community Health"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10900-026-01581-y","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:31:17Z","timestamp":1779085877000},"page":"648-655","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-Adherence to Anti-Tuberculosis Treatment and Its Determinants Among Tuberculosis Patients in Tanzania"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2236-9852","authenticated-orcid":false,"given":"Meshack","family":"Morice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5568-5551","authenticated-orcid":false,"given":"Bernadetha Hugho","family":"Kimario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indo","family":"Ndaigeze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1633-5213","authenticated-orcid":false,"given":"Damas Dismas","family":"Nyabenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"1581_CR1","unstructured":"CDA (2025). Tuberculosis. In: Communicable Diseases Agency. https:\/\/www.cda.gov.sg\/public\/diseases\/tuberculosis\/. Accessed 16 Apr 2026."},{"key":"1581_CR2","unstructured":"WHO (2026). Tuberculosis (TB). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tuberculosis. Accessed 16 Apr 2026."},{"key":"1581_CR3","unstructured":"CDC (2025). Tuberculosis: Causes and How It Spreads. In: Tuberculosis (TB). https:\/\/www.cdc.gov\/tb\/causes\/index.html. Accessed 16 Apr 2026."},{"key":"1581_CR4","unstructured":"Yen, T. S. (2026). Latent and Active Tuberculosis, What Is the Difference - National Centre for Infectious Diseases. https:\/\/www.ncid.sg\/Health-Professionals\/Articles\/Pages\/Latent-and-Active-Tuberculosis,-What-Is-the-Difference.aspx. Accessed 16 Apr 2026."},{"key":"1581_CR5","first-page":"210","volume":"35","author":"NA Chebet","year":"2022","unstructured":"Chebet, N. A., Kirui, J., Otieno, G., Sanga, D., Wanjau, G., & Yoos, A. (2022). Tuberculosis Treatment Adherence among Patients Taking Anti-TB Drugs in Kilifi County, Kenya. African Journal of Health Sciences, 35, 210\u2013223.","journal-title":"African Journal of Health Sciences"},{"key":"1581_CR6","unstructured":"World Health Organization. (2025). WHO consolidated guidelines on tuberculosis: Module 4: Treatment and care. World Health Organization."},{"key":"1581_CR7","unstructured":"WHO (2026). The End TB Strategy. https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/the-end-tb-strategy. Accessed 16 Apr 2026."},{"key":"1581_CR8","doi-asserted-by":"publisher","unstructured":"Ferreira, I. B. B., Menezes, R. C., Ara\u00fajo-Pereira, M., Rolla, V. C., Kritski, A. L., Cordeiro-Santos, M., Sterling, T. R., Staats, C., Amorim, G., Trajman, A., Andrade, B. B., Benjamin, A., Medeiros, Q., Ridolfi, F., Gomes-Silva, A., Oliveira, J., Marine, J., Durovni, B., Cavalcante, S., Rezende, A., Bezerra, A., Carvalho, A., Brito, A., Costa, A., Spener-Gomes, R., Rocha, M., Nascimento, V., Nogueira, B., Andrade, A., & Silva, E. (2025). Effects of missed anti-tuberculosis therapy doses on treatment outcome: a multi-center cohort study. The Lancet Regional Health \u2013 Americas, 48. https:\/\/doi.org\/10.1016\/j.lana.2025.101162","DOI":"10.1016\/j.lana.2025.101162"},{"key":"1581_CR9","doi-asserted-by":"publisher","first-page":"e0287628","DOI":"10.1371\/journal.pone.0287628","volume":"18","author":"DB Lolong","year":"2023","unstructured":"Lolong, D. B., Aryastami, N. K., Kusrini, I., Tobing, K. L., Tarigan, I., Isfandari, S., Senewe, F. P., Raflizar, Endah, N., Sitorus, N., Pangaribuan, L., Simarmata, O. S., & Ariati, Y. (2023). Nonadherence to anti-tuberculosis treatment, reasons and associated factors among pulmonary tuberculosis patients in the communities in Indonesia. PLOS ONE, 18, e0287628. https:\/\/doi.org\/10.1371\/journal.pone.0287628","journal-title":"PLOS ONE"},{"key":"1581_CR10","doi-asserted-by":"publisher","first-page":"e0280396","DOI":"10.1371\/journal.pone.0280396","volume":"18","author":"AW Mbuya","year":"2023","unstructured":"Mbuya, A. W., Mboya, I. B., Semvua, H. H., Mamuya, S. H., & Msuya, S. E. (2023). Prevalence and factors associated with tuberculosis among the mining communities in Mererani, Tanzania. PLOS ONE, 18, e0280396. https:\/\/doi.org\/10.1371\/journal.pone.0280396","journal-title":"PLOS ONE"},{"key":"1581_CR11","unstructured":"WHO AFRICA (2026). Tuberculosis (TB) | WHO | Regional Office for Africa. https:\/\/www.afro.who.int\/health-topics\/tuberculosis-tb. Accessed 16 Apr 2026."},{"key":"1581_CR12","doi-asserted-by":"publisher","unstructured":"Li, S., Mensah, E., Liu, M., Pan, L., Lu, W., Zhou, S., Zhang, L., Cheng, Y., Zhao, H., Wei, S., & Zha, L. (2025). The burden of tuberculosis and drug resistance in 22 Sub-Saharan African countries, 1990\u20132021: a GBD 2021 analysis and progress towards WHO 2035 targets with projections to 2050. Frontiers In Microbiology, 16. https:\/\/doi.org\/10.3389\/fmicb.2025.1695592","DOI":"10.3389\/fmicb.2025.1695592"},{"key":"1581_CR13","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1186\/s12889-020-09827-7","volume":"20","author":"D Ajema","year":"2020","unstructured":"Ajema, D., Shibru, T., Endalew, T., & Gebeyehu, S. (2020). Level of and associated factors for non-adherence to anti-tuberculosis treatment among tuberculosis patients in Gamo Gofa zone, southern Ethiopia: cross-sectional study. Bmc Public Health, 20, 1705. https:\/\/doi.org\/10.1186\/s12889-020-09827-7","journal-title":"Bmc Public Health"},{"key":"1581_CR14","doi-asserted-by":"publisher","unstructured":"Lemma Tirore, L., Ersido, T., Beyene Handiso, T., & Shiferaw Areba, A. (2024). Non-adherence to anti-tuberculosis treatment and associated factors among TB patients in public health facilities of Hossana town, Southern Ethiopia, 2022. Front Med 11:. https:\/\/doi.org\/10.3389\/fmed.2024.1360351","DOI":"10.3389\/fmed.2024.1360351"},{"key":"1581_CR15","unstructured":"WHO (2026). 6. Treatment of drug-resistant TB using longer regimens | TB Knowledge Sharing|Department for HIV, Tuberculosis, Hepatitis & Sexually Transmitted Infections (HTH). https:\/\/tbksp.who.int\/en\/node\/3037. Accessed 16 Apr 2026."},{"key":"1581_CR16","doi-asserted-by":"publisher","unstructured":"Barreto-Duarte, B., Villalva-Serra, K., Croda, J., Arc\u00eancio, R. A., Maciel, E. L. N., & Andrade, B. B. (2025). Directly observed treatment for tuberculosis care and social support: essential lifeline or outdated burden? The Lancet Regional Health \u2013 Americas, 43. https:\/\/doi.org\/10.1016\/j.lana.2025.101015","DOI":"10.1016\/j.lana.2025.101015"},{"key":"1581_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4046\/trd.2022.0148","volume":"86","author":"MF Sazali","year":"2022","unstructured":"Sazali, M. F., Rahim, S. S. S. A., Mohammad, A. H., Kadir, F., Payus, A. O., Avoi, R., Jeffree, M. S., Omar, A., Ibrahim, M. Y., Atil, A., Tuah, N. M., Dapari, R., Lansing, M. G., Rahim, A. A. A., & Azhar, Z. I. (2022). Improving Tuberculosis Medication Adherence: The Potential of Integrating Digital Technology and Health Belief Model. Tuberculosis And Respiratory Diseases, 86, 82\u201393. https:\/\/doi.org\/10.4046\/trd.2022.0148","journal-title":"Tuberculosis And Respiratory Diseases"},{"key":"1581_CR18","doi-asserted-by":"publisher","first-page":"e0318174","DOI":"10.1371\/journal.pone.0318174","volume":"20","author":"S Turyahabwe","year":"2025","unstructured":"Turyahabwe, S., Ramachandra, S. S., Quraishi, S., Fasih, I., Quraishi, H., Peddapalegani, P., & Ahmad, A. (2025). A community based, bottom-up, multi-pronged, technology integrated approach to enhance tuberculosis related awareness and treatment adherence in Uganda: The ACTS model. PLOS ONE, 20, e0318174. https:\/\/doi.org\/10.1371\/journal.pone.0318174","journal-title":"PLOS ONE"},{"key":"1581_CR19","unstructured":"World Health Organization (2020). United Republic of Tanzania \u2013 TB Community Network: a platform for a stronger community response to tuberculosis. https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/426b8d22-5e90-4d86-ae79-28e2bc08e3b4\/content. Accessed 16 Apr 2026."},{"key":"1581_CR20","unstructured":"NTLP (2023). TB Burden in Tanzania | National Tuberculosis & Leprosy Programme. https:\/\/ntlp.go.tz\/tuberculosis\/tb-prevalence-in-tanzania\/. Accessed 16 Apr 2026."},{"key":"1581_CR21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s41043-021-00275-6","volume":"40","author":"RB Gebremariam","year":"2021","unstructured":"Gebremariam, R. B., Wolde, M., & Beyene, A. (2021). Determinants of adherence to anti-TB treatment and associated factors among adult TB patients in Gondar city administration, Northwest, Ethiopia: based on health belief model perspective. Journal Of Health, Population, And Nutrition, 40, 49. https:\/\/doi.org\/10.1186\/s41043-021-00275-6","journal-title":"Journal Of Health, Population, And Nutrition"},{"key":"1581_CR22","doi-asserted-by":"publisher","unstructured":"Bea, S., Lee, H., Kim, J. H., Jang, S. H., Son, H., Kwon, J-W., & Shin, J-Y. (2021). Adherence and Associated Factors of Treatment Regimen in Drug-Susceptible Tuberculosis Patients. Frontiers In Pharmacology, 12. https:\/\/doi.org\/10.3389\/fphar.2021.625078","DOI":"10.3389\/fphar.2021.625078"},{"key":"1581_CR23","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ijtb.2024.05.005","volume":"72","author":"MH Stanikzai","year":"2025","unstructured":"Stanikzai, M. H., Wafa, M. H., Baray, A. H., Rahimi, A. F., & Sayam, H. (2025). Anti-TB treatment non-adherence predictors: A multi-center cross-sectional study in Kandahar, Afghanistan. Indian Journal of Tuberculosis, 72, 298\u2013303. https:\/\/doi.org\/10.1016\/j.ijtb.2024.05.005","journal-title":"Indian Journal of Tuberculosis"},{"key":"1581_CR24","doi-asserted-by":"publisher","first-page":"476","DOI":"10.24171\/j.phrp.2025.0153","volume":"16","author":"M Dellal","year":"2025","unstructured":"Dellal, M., Batoui, S., Aassem, Y., & Habbari, K. (2025). Factors influencing adherence to anti-tuberculosis treatment in Morocco: a cross-sectional study from the B\u00e9ni Mellal-Kh\u00e9nifra region. PHRP, 16, 476\u2013485. https:\/\/doi.org\/10.24171\/j.phrp.2025.0153","journal-title":"PHRP"},{"key":"1581_CR25","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/j.jiph.2023.09.005","volume":"16","author":"C-S Lee","year":"2023","unstructured":"Lee, C-S., Ho, C-H., Liao, K-M., Wu, Y-C., & Shu, C-C. (2023). The incidence of tuberculosis recurrence: Impacts of treatment duration of and adherence to standard anti-tuberculous therapy. Journal of Infection and Public Health, 16, 1778\u20131783. https:\/\/doi.org\/10.1016\/j.jiph.2023.09.005","journal-title":"Journal of Infection and Public Health"},{"key":"1581_CR26","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/QAI.0000000000002940","volume":"90","author":"MR O\u2019Donnell","year":"2022","unstructured":"O\u2019Donnell, M. R., Padayatchi, N., Wolf, A., Zelnick, J., Daftary, A., Orrell, C., Nimmo, C., Baldwin, M., Boodhram, R., Maharaj, B., Amico, K. R., Naidoo, K., & Friedland, G. (2022). Bedaquiline Adherence Measured by Electronic Dose Monitoring Predicts Clinical Outcomes in the Treatment of Patients With Multidrug-Resistant Tuberculosis and HIV\/AIDS. JAIDS Journal of Acquired Immune Deficiency Syndromes, 90, 325. https:\/\/doi.org\/10.1097\/QAI.0000000000002940","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"key":"1581_CR27","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1111\/bcp.15515","volume":"89","author":"WS Fox","year":"2023","unstructured":"Fox, W. S., Strydom, N., Imperial, M. Z., Jarlsberg, L., & Savic, R. M. (2023). Examining nonadherence in the treatment of tuberculosis: The patterns that lead to failure. British Journal of Clinical Pharmacology, 89, 1965\u20131977. https:\/\/doi.org\/10.1111\/bcp.15515","journal-title":"British Journal of Clinical Pharmacology"},{"key":"1581_CR28","doi-asserted-by":"publisher","first-page":"e571","DOI":"10.1093\/cid\/ciaf467","volume":"82","author":"S Law","year":"2026","unstructured":"Law, S., Fulcher, I., Ashraf, S., Bastard, M., Docteur, W., Franke, M. F., Guerra, D., Hewison, C., Huerga, H., Khan, M., Khan, P., Khan, U., Kliescikova, J., Kumsa, A., Lomtadze, N., Putri, F. A., Rich, M. L., Seung, K., Skrahina, A., Tamirat, M., Vo, L. N. Q., & Mitnick, C. D. (2026). Characterizing Treatment Adherence Trajectories in the endTB Multisite Cohort of Drug-Resistant Tuberculosis Patients: An Application of Group-Based Trajectory Modeling. Clinical Infectious Diseases, 82, e571\u2013e579. https:\/\/doi.org\/10.1093\/cid\/ciaf467","journal-title":"Clinical Infectious Diseases"},{"key":"1581_CR29","doi-asserted-by":"publisher","unstructured":"Amalba, A., & Bugri, A. A. (2021). Assessing the prevalence and effect of adverse drug reactions among patients receiving first line anti-tubercular medicines in the Tamale Teaching Hospital, Ghana. The Pan African Medical Journal, 38. https:\/\/doi.org\/10.11604\/pamj.2021.38.191.24301","DOI":"10.11604\/pamj.2021.38.191.24301"},{"key":"1581_CR30","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1186\/s12889-023-16259-6","volume":"23","author":"MA Appiah","year":"2023","unstructured":"Appiah, M. A., Arthur, J. A., Gborgblorvor, D., Asampong, E., Kye-Duodu, G., Kamau, E. M., & Dako-Gyeke, P. (2023). Barriers to tuberculosis treatment adherence in high-burden tuberculosis settings in Ashanti region, Ghana: a qualitative study from patient\u2019s perspective. Bmc Public Health, 23, 1317. https:\/\/doi.org\/10.1186\/s12889-023-16259-6","journal-title":"Bmc Public Health"},{"key":"1581_CR31","doi-asserted-by":"publisher","first-page":"5626","DOI":"10.3390\/ijerph17155626","volume":"17","author":"ZS Nezenega","year":"2020","unstructured":"Nezenega, Z. S., Perimal-Lewis, L., & Maeder, A. J. (2020). Factors Influencing Patient Adherence to Tuberculosis Treatment in Ethiopia: A Literature Review. International Journal of Environmental Research and Public Health, 17, 5626. https:\/\/doi.org\/10.3390\/ijerph17155626","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"1581_CR32","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1186\/s12889-021-10698-9","volume":"21","author":"R Adisa","year":"2021","unstructured":"Adisa, R., Ayandokun, T. T., & Ige, O. M. (2021). Knowledge about tuberculosis, treatment adherence and outcome among ambulatory patients with drug-sensitive tuberculosis in two directly-observed treatment centres in Southwest Nigeria. Bmc Public Health, 21, 677. https:\/\/doi.org\/10.1186\/s12889-021-10698-9","journal-title":"Bmc Public Health"},{"key":"1581_CR33","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1186\/s12879-020-05354-3","volume":"20","author":"X Chen","year":"2020","unstructured":"Chen, X., Du, L., Wu, R., Xu, J., Ji, H., Zhang, Y., Zhu, X., & Zhou, L. (2020). The effects of family, society and national policy support on treatment adherence among newly diagnosed tuberculosis patients: a cross-sectional study. Bmc Infectious Diseases, 20, 623. https:\/\/doi.org\/10.1186\/s12879-020-05354-3","journal-title":"Bmc Infectious Diseases"},{"key":"1581_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41533-020-0179-x","volume":"30","author":"IS Pradipta","year":"2020","unstructured":"Pradipta, I. S., Houtsma, D., van Boven, J. F. M., Alffenaar, J-W-C., & Hak, E. (2020). Interventions to improve medication adherence in tuberculosis patients: a systematic review of randomized controlled studies. npj Prim Care Respir Med, 30, 21. https:\/\/doi.org\/10.1038\/s41533-020-0179-x","journal-title":"npj Prim Care Respir Med"},{"key":"1581_CR35","doi-asserted-by":"publisher","first-page":"11150","DOI":"10.1038\/s41598-025-96260-8","volume":"15","author":"B Alinaitwe","year":"2025","unstructured":"Alinaitwe, B., Shariff, N. J., & Madhavi Boddupalli, B. (2025). Treatment adherence and its association with family support among pulmonary tuberculosis patients in Jinja, Eastern Uganda. Scientific Reports, 15, 11150. https:\/\/doi.org\/10.1038\/s41598-025-96260-8","journal-title":"Scientific Reports"},{"key":"1581_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.19080\/CRDOJ.2022.16.555927","volume":"16","author":"UA Ayonote","year":"2022","unstructured":"Ayonote, U. A., Akujuobi, O. M., & Ogbonna, A. N. (2022). Family Social Support Perceptions and Medication Adherence among Elderly Diabetics in a Tertiary Health Institution in Lagos, Nigeria. CRDOJ, 16, 1\u20139. https:\/\/doi.org\/10.19080\/CRDOJ.2022.16.555927","journal-title":"CRDOJ"},{"key":"1581_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.70109\/jinher.v1i1.4","volume":"1","author":"N Karlina","year":"2025","unstructured":"Karlina, N., Mardiani, A., Kamasturyani, Y., Wahyuni, U., & Amelia, V. L. (2025). Family Support and Medication Adherence to Anti-Tuberculosis Drug Therapy: A Cross-Sectional Study. Journal of Integrated Health Research, 1, 7\u201312. https:\/\/doi.org\/10.70109\/jinher.v1i1.4","journal-title":"Journal of Integrated Health Research"}],"container-title":["Journal of Community Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10900-026-01581-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10900-026-01581-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10900-026-01581-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T18:46:39Z","timestamp":1784573199000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10900-026-01581-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1581"],"URL":"https:\/\/doi.org\/10.1007\/s10900-026-01581-y","relation":{},"ISSN":["0094-5145","1573-3610"],"issn-type":[{"value":"0094-5145","type":"print"},{"value":"1573-3610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"17 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author(s) declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from Kairuki University. Permission to conduct the study was also granted by the Mwananyamala Hospital administration (Ref.No: MA.59\/240\/01\/156). All participants were informed about the study objectives, procedures, risks, and benefits in prior to participation. Participation was entirely voluntary, and respondents could withdraw at any time without consequence. Participant confidentiality and anonymity were maintained by assigning unique identification codes and excluding personally identifiable information.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all the participants included in the study prior to data collection.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}